Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Despite initial pharmaceutical interest, AOD 9604 did not progress through the full clinical trial pathway required for regulatory approval, and it holds no Marketing Authorisation (MA) from the MHRA or EMA
It is sometimes used in conjunction with other metabolic support peptides such as MOTS-c or CJC-1295/Ipamorelin for comprehensive metabolic optimization
Understanding these pathways helps explain why the peptide shows such broad therapeutic potential across different tissue types
Complements regular exercise, balanced nutrition, and adequate rest
GP consultations only blood tests, IV drips, physio, home-visit fees and other services are excluded
US$ 24.98
US$ 22.91
US$ 27.30
US$ 20.75
US$ 20.22
